Atlas Trials

Safety and Efficacy of a Single Suprachoroidal Injection of JWK010 Gene Therapy in Subjects With Oculocutaneous Albinism Type 1 (OCA1)

Clinical trial NCT07313618 · RECRUITING

Trial details

NCT number
NCT07313618
Sponsor
West China Hospital
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Oculocutaneous Albinism (OCA)
Start date
2025-12-22
Primary completion
2030-12-31
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.